MHRA approves first oral advanced therapy for Crohn's disease

The MHRA has approved the first marketing authorisation globally for the use of upadacitinib in Crohn's disease.

Related Keywords

United Kingdom ,Great Britain ,James Lindsay ,Belinda Byrne ,Royal London Hospital Barts Health ,Regulatory Agency ,Professor James Lindsay ,Consultant Gastroenterologist ,Medical Director ,Abbvie United ,